Stefania De Lorenzo - Concepedia

Author

Stefania De Lorenzo

IRCCS Azienda Ospedliero-Universitaria di Bologna Policlinico di Sant'Orsola ORCID

Also Known As

De Lorenzo, S., S . De Lorenzo, S De Lorenzo, S Lorenzo, S. De Lorenzo, S. Lorenzo, STEFANIA DE LORENZO, Shirley Lorenzo, Simone Di Lorenzo, Sophie Lorenzo

101

Publications

1.4K

Citations

H-Index

Concepts

All Affiliations

IRCCS Azienda Ospedliero-Universitaria di Bologna Policlinico di Sant'Orsola University of Bologna Istituti di Ricovero e Cura a Carattere Scientifico Azienda USL di Bologna Medica (Italy)

About

Stefania De Lorenzo is an author at IRCCS Azienda Ospedliero-Universitaria di Bologna Policlinico di Sant'Orsola specializing in medicine, hepatology, and radiation oncology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	2	2	95
2	Hepatology	2	2	95
3	Pathology	2	2	95
4	Pharmacology	1	1	77
5	Cancer Genetics	1	1	18

Stefania De Lorenzo

Publications

596

Citations

H-Index

Page 1

	Year	Citations
Percutaneous radiofrequency ablation in intrahepatic cholangiocarcinoma: a retrospective single-center experience Giovanni Brandi, Alessandro Rizzo, Filippo Gustavo Dall’Olio, International Journal of Hyperthermia	2020	111
Metronomic capecitabine vs. best supportive care in Child-Pugh B hepatocellular carcinoma: a proof of concept Stefania De Lorenzo, Francesco Tovoli, Maria Aurelia Barbera, Scientific Reports	2018	99
Metronomic capecitabine as second-line treatment for hepatocellular carcinoma after sorafenib discontinuation Franco Trevisani, Giovanni Brandi, Francesca Garuti, Journal of Cancer Research and Clinical Oncology Second-line TreatmentHepatologyMedicineMetronomic TherapyPharmacology	2017	77
Is post‐transplant chemotherapy feasible in liver transplantation for colorectal cancer liver metastases? Giovanni Brandi, Angela Dalia Ricci, Alessandro Rizzo, Cancer Communications	2020	63
Non-Alcoholic Steatohepatitis as a Risk Factor for Intrahepatic Cholangiocarcinoma and Its Prognostic Role Stefania De Lorenzo, Francesco Tovoli, Alessandro Mazzotta, Cancers	2020	51
Real-Life Clinical Data of Cabozantinib for Unresectable Hepatocellular Carcinoma Francesco Tovoli, Vincenzo Dadduzio, Stefania De Lorenzo, Liver Cancer	2021	48
Membrane Localization of Human Equilibrative Nucleoside Transporter 1 in Tumor Cells May Predict Response to Adjuvant Gemcitabine in Resected Cholangiocarcinoma Patients Giovanni Brandi, Marzia Deserti, Francesco Vasuri, The Oncologist	2016	29
Chemotherapy toxicity and activity in patients with pancreatic ductal adenocarcinoma and germline BRCA1-2 pathogenic variants (gBRCA1-2pv): a multicenter survey Giulia Orsi, Mariacristina Di Marco, Alessandro Cavaliere, ESMO Open	2021	20
The role of metronomic capecitabine for treatment of recurrent hepatocellular carcinoma after liver transplantation Matteo Ravaioli, Alessandro Cucchetti, Antonio Daniele Pinna, Scientific Reports	2017	19
Surveillance for Hepatocellular Carcinoma Also Improves Survival of Incidentally Detected Intrahepatic Cholangiocarcinoma Arisen in Liver Cirrhosis Francesco Tovoli, Pietro Guerra, Massimo Iavarone, Liver Cancer	2020	19

Page 1